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Uropathogenic Escherichia coli (UPEC), the primary causative agent of urinary tract infections, typically express
filamentous adhesive organelles called type 1 pili that mediate both bacterial attachment to and invasion of bladder
urothelial cells. Several host proteins have previously been identified as receptors for type 1 pili, but none have been
conclusively shown to promote UPEC entry into host bladder cells. Using overlay assays with FimH, the purified type 1
pilus adhesin, and mass spectroscopy, we have identified b1 and a3 integrins as key host receptors for UPEC. FimH
recognizes N-linked oligosaccharides on these receptors, which are expressed throughout the urothelium. In a bladder
cell culture system, b1 and a3 integrin receptors co-localize with invading type 1–piliated bacteria and F-actin. FimH-
mediated bacterial invasion of host bladder cells is inhibited by b1 and a3 integrin–specific antibodies and by
disruption of the b1 integrin gene in the GD25 fibroblast cell line. Phosphorylation site mutations within the
cytoplasmic tail of b1 integrin that alter integrin signaling also variably affect UPEC entry into host cells, by either
attenuating or boosting invasion frequencies. Furthermore, focal adhesion and Src family kinases, which propagate
integrin-linked signaling and downstream cytoskeletal rearrangements, are shown to be required for FimH-dependent
bacterial invasion of target host cells. Cumulatively, these results indicate that b1 and a3 integrins are functionally
important receptors for type 1 pili–expressing bacteria within the urinary tract and possibly at other sites within the
host.
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Introduction
Host cell invasion contributes to the ability of many
bacterial pathogens to colonize, multiply, disseminate, and, in
some cases, persist for weeks to months within their animal
hosts. In recent years, many bacteria that had previously been
characterized as strictly extracellular microbes have been
shown to behave as opportunistic intracellular pathogens [1].
Among these invasive bacteria are strains of uropathogenic
Escherichia coli (UPEC). Worldwide, UPEC accounts for the
majority of urinary tract infections (UTIs), including both
cystitis (bladder infection) and pyelonephritis (kidney in-
fection) [2]. These infections are exceedingly common in
females, affecting about 11% of women each year [3]. The
propensity of these infections to recur adds greatly to their
problematic nature. By some estimates, more than 25% of
women will endure a second UTI within 6 mo of an initial
bladder infection, and about 3% will experience a third [4,5].
Cell culture and mouse UTI model systems suggest that UPEC
invasion of host tissues within the urinary tract contributes
signiﬁcantly to the establishment as well the persistence and
recurrence of UTIs [6–13].
UPEC are now known to utilize a number of diverse
mechanisms to enter host epithelial cells [1,14]. These
mechanisms include manipulation of host Rho GTPases by
the secreted UPEC-associated toxin CNF1 [15], the hijacking,
via opsonization, of host complement receptors [16,17], and
the expression by UPEC of ﬁlamentous adhesive organelles
known as type 1 pili [18]. Virtually all UPEC isolates and many
other species within the Enterobacteriaceae family encode
type 1 pili (also known as type 1 ﬁmbriae) [19–21]. These
peritrichously expressed organelles are composite ﬁbers
made up of a 7-nm-wide helical rod comprised of repeating
FimA subunits joined to a distal 3-nm-thick tip ﬁbrillum
consisting of two adaptor proteins, FimF and FimG, and the
adhesin FimH [22,23]. Type 1 pili, and in particular the FimH
adhesin, are critical to the ability of UPEC to effectively
colonize the urinary tract [8,19,24,25].
FimH possesses an N-terminal carbohydrate-binding pock-
et that enables type 1–piliated E. coli to bind mannose-
containing host glycoprotein receptors and thereby mediate
both bacterial adherence to and invasion of target host cells
[18,26]. Studies using ﬁmH-null mutants and puriﬁed FimH
have demonstrated that this adhesin is sufﬁcient for
mediating E. coli entry into bladder epithelial cells [18]. Once
internalized, UPEC is trafﬁcked into membrane-bound acidic
compartments with many features that are characteristic of
late endosomes and lysosomes [10,18]. Within these compart-
ments, UPEC replication is restricted. However, upon entry
into the host cytosol, UPEC can rapidly multiply, forming
large bioﬁlm-like inclusions that occupy much of the host cell
interior [6,9,10,27]. These inclusions are known variably as
bacterial factories, pods, or intracellular bacterial commun-
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terminally differentiated superﬁcial umbrella cells that line
the lumenal surface of the bladder. Umbrella cells, along with
two to three layers of underlying immature basal and
intermediate epithelial cells, comprise the urothelium.
The stratiﬁed cell layers of the urothelium act as a
formidable permeability barrier, restricting the diffusion of
solutes from urine into associated tissue [28]. However,
during the course of a UTI, this barrier is compromised
due to the induced exfoliation of infected superﬁcial
umbrella cells and the inﬂux of immune cells [1,8,13].
Consequently, UPEC is able to penetrate beyond the super-
ﬁcial cell layer and invade underlying immature host cells
[9,10]. UPEC growth within these epithelial cells is limited,
and the bacteria seem to enter a more quiescent state that is
in part modulated by the host actin cytoskeleton. We have
hypothesized that UPEC that manage to invade and persist
quiescently within the immature cells of the bladder
urothelium act as a source for recurrent acute UTIs [10].
How FimH promotes UPEC invasion of bladder epithelial
cells is not entirely clear. Cell culture studies have revealed
that FimH-mediated host cell invasion requires phosphoino-
sitide 3-kinase (PI 3-kinase) activation and localized host actin
rearrangements [18]. Rho GTPases and lipid rafts are also
implicated in the invasion process, along with focal adhesion
kinase (FAK) activation and transient complex formation
between the cytoskeleton stabilizing and scaffolding compo-
nents a-actinin and vinculin [18,29,30]. However, the FimH
host receptor(s) involved in initiating the cascade of signaling
events leading to UPEC entry into bladder epithelial cells is
unknown. FimH interactions with several glycosylated and
nonglycosylated host factors have been documented. These
include components of the glycocalyx that sparsely covers the
bladder surface [31], a few extracellular matrix (ECM)
proteins [32–34], carcinoembryonic antigen-related cell
adhesion molecule (CEACAM) family members [35,36],
soluble Tamm-Horsfall protein [37], the glycosylphosphati-
dylinositol (GPI)-anchored protein CD48 [38,39], the leuko-
cyte adhesion molecules CD11 and CD18 [40], and uroplakin
1a (UP1a) [41]. Here, we identify b1 and a3 integrins, which
are distributed throughout the urothelium, as key mediators
of host cell invasion by type 1–piliated E. coli. In addition, we
show that FimH-mediated bacterial entry into host cells is
modulated by speciﬁc phosphorylation sites within the
cytoplasmic tail of b1 integrin and by downstream integrin-
linked signaling factors.
Results
Identification of Potential FimH Receptors
To search for host receptors that might promote FimH-
mediated bacterial invasion of bladder epithelial cells, we ﬁrst
puriﬁed the FimH adhesin. FimH is assembled into the distal
tips of type 1 pili via a canonical chaperone-usher pathway
[23,42]. In the absence of the periplasmic chaperone FimC,
FimH, as well as other type 1 pilus subunits, misfold and are
subsequently degraded. In order to purify native full-length
FimH, the adhesin was coordinately expressed in BL21(DE3)
E. coli cells with FimC, which was doubly tagged with
consecutive COOH-terminal 6XHis and FLAG epitopes.
These tags facilitated the puriﬁcation of FimC–FimH com-
plexes using afﬁnity chromatography and allowed for cleaner
detection of the complexes in later Far Western overlay
assays.
Next, host membrane-associated proteins isolated from a
human bladder epithelial cell line designated 5637 were
resolved by SDS-PAGE and transferred to polyvinylidene
ﬂuoride (PVDF) membranes. These membranes were incu-
bated with puriﬁed FimC6XHisFLAG or with FimC6XHisFLAG–
FimH complexes in the presence or absence of 2.5% D-
mannose, which acts as a soluble FimH receptor analog. All
blots were subsequently probed using an anti-FLAG antibody
and chemiluminescence. In these Far Western overlay assays,
no bands were bound by puriﬁed FimC6XHisFLAG alone or by
FimC6XHisFLAG–FimH complexes in the presence of D-
mannose (Figure 1). However, in the absence of D-mannose,
approximately 15 bands bound by FimC6XHisFLAG–FimH were
detected. The mannose sensitivity of these interactions, as
well as the lack of FimC6XHisFLAG binding, indicates that they
are mediated by FimH and not FimC. The two most
prominent bands bound by FimH (Figure 1, bracketed) had
molecular weights of approximately 120 and 150 kDa. These
bands were excised from a duplicate GelCode Blue–stained
gel, trypsin digested, and shown by mass spectroscopy to be
composed of (in order of prevalence of the detected peptides)
a2, b1, a3, a6, and b4 integrins. The presence of b4 integrin–
speciﬁc sequences within these bands is surprising since this
integrin has an apparent molecular weight of over 200 kDa,
substantially above the range of the isolated 120- and 150-kDa
bands. Nevertheless, we did not use this discrepancy as a basis
to exclude b4 integrin as a FimH receptor candidate.
Integrins are surface adhesion molecules, comprised of a
and b subunit heterodimers, that connect ECM proteins with
the actin cytoskeleton [43]. Currently, there are 18 known a
and eight b subunits that can combine to form at least 24
different heterodimeric integrin complexes with varying
ligand-binding speciﬁcities. b subunits, and in particular b1,
can interact with multiple a subunits. Many pathogens,
including human cytomegalovirus, Group A Streptococcus,
Yersinia spp., and AfaD
þE. coli, gain entry into target host cells
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Author Summary
Strains of bacteria called uropathogenic Escherichia coli (UPEC) are
the primary cause of urinary tract infections (UTIs), which by some
estimates are the second most common type of infectious disease in
the world today. UPEC strains typically express hair-like fibers called
type 1 pili on their surface that allow them to bind and invade the
host cells that line the urinary tract. The ability of UPEC to enter
these host cells likely promotes the establishment and persistence
of UTIs. The invasion process requires that the incoming pathogens
first bind specific receptor molecules on the target cell surface. Here,
we identify two host proteins known as b1 and a3 integrin as key
receptors for type 1 pili–expressing UPEC. The adhesive tips of type
1 pili recognize sugars that decorate these integrin receptors,
thereby activating a signaling cascade that stimulates the host
plasma membrane to zipper around and envelop bound bacteria. b1
and a3 integrins have important roles in a number of host cell
functions and are widely distributed within the urinary tract and in
other tissues. Interestingly, type 1 pili are expressed by many
different types of bacteria in addition to UPEC, raising the possibility
that interactions between type 1 pili and integrin receptors can
facilitate bacterial colonization within diverse niches throughout the
host.by binding integrins either directly or indirectly via matrix
proteins such as ﬁbronectin [44–50]. Our data from Far
Western overlay assays, which were performed in the absence
of any established integrin ligands, suggest that FimH is able
to directly interact in a mannose-sensitive fashion with one or
more of the ﬁve integrin subunits identiﬁed above.
Antibodies against b1 and a3 Integrins Inhibit Host Cell
Invasion by UPEC
To test the functional role of the putative FimH receptors
(b1, b4, a2, a3, and a6 integrins) in mediating UPEC entry
into host cells, we employed a modiﬁed gentamicin protec-
tion–based invasion assay (see Materials and Methods and
[51]). 5637 bladder epithelial cells were incubated with
monoclonal antibodies directed against speciﬁc integrin
subunits prior to infection with either UTI89, a well-
characterized human cystitis isolate [6,9,10,27,52], or
AAEC185/pSH2, a type 1 pili–expressing recombinant labo-
ratory K-12 E. coli strain [8,18]. Both UTI89 and AAEC185/
pSH2 require expression of the FimH adhesin in order to
adhere to and effectively invade bladder epithelial cells. We
found that a b1 integrin–blocking antibody, 6S6, notably
decreased UTI89 invasion of host 5637 bladder epithelial cells
(Figure 2A). The b1 integrin–activating antibody P4G11 and
the anti–a3 integrin antibody P1B5 had similar effects in
inhibiting bacterial invasion. Antibodies against the other
putative FimH receptors (a2, a6, and b4 integrins) did not
signiﬁcantly affect UTI89 entry into the bladder epithelial
cells and served as convenient isotype controls. Similar
invasion results were observed in complementary experi-
ments using AAEC185/pSH2. Both the b1 integrin–blocking
antibody 6S6 and the anti–a3 integrin antibody P1B5 notably
attenuated AAEC185/pSH2 invasion of 5637 cells, while an
anti–a2 integrin control antibody had no effect (Figure 2C).
None of the antibodies had any signiﬁcant effect on the total
numbers of cell-associated bacteria, with the exception of the
anti–a3 integrin antibody, which for unknown reasons caused
a slight increase in the numbers of cell-associated AAEC185/
pSH2 (Figure 2B and 2D). Increasing the concentration of the
antibodies used by up to 8-fold gave similar results in both
the invasion and adherence assays. Importantly, control
studies showed that none of the antibodies utilized in these
assays cross-reacted or interfered with either the growth or
viability of UTI89 and AAEC185/pSH2. The combined use of
anti–a3 and anti–b1 integrin antibodies did not have a
cumulative inhibitory effect on UTI89 invasion (unpublished
data).
Localization of Type 1–Piliated E. coli with b1 and a3
Integrins
Immunoﬂuorescence confocal microscopy was used to
determine whether b1 and a3 integrin subunits localize in
bladder epithelial cells with adherent and/or invading type 1
pili–expressing E. coli. 5637 bladder cells were infected for 30
min with either the cystitis isolate UTI89 or AAEC185/pSH2.
Samples were stained using primary antibodies speciﬁc for
the individual b1 and a3 subunits or for a3b1 heterodimeric
complexes. Fluorescently tagged phalloidin was used to
visualize F-actin. Analysis of single cross sections from
confocal z-stacks revealed that b1 and a3 subunits, as well
as a3b1 heterodimers and F-actin, co-localize around
adherent and invading UTI89 (Figure 3A–3C). In addition,
F-actin and a3b1 integrin heterodimers were also found in
association with type 1–piliated bacteria that had already
penetrated into the bladder epithelial cells, below the host
cell surface (Figure 3D). Similar results were seen with
AAEC185/pSH2-infected bladder cells (Figure 3E–3G). In
contrast, bacterial co-localization with F-actin and the a3
and b1 integrin subunits was not detected in bladder cells
infected with either of the ﬁmH-null mutants DﬁmH UTI89 or
AAEC185/pUT2002. These results suggest a scenario in which
FimH-mediated clustering of a3b1 integrin receptors triggers
localized actin rearrangements that lead to the envelopment
and internalization of type 1–piliated E. coli.
Glycosidase Treatment of b1 and a3 Integrins Abrogates
FimH Binding
The capacity of FimH to act as a lectin and bind mannose-
containing structures is critical to its role as a mediator of
bacterial adherence and invasion [18,53–55]. Our data suggest
that FimH binds b1 and a3 integrin receptors directly,
presumably via interactions with one or more of the N-linked
sugar side chains that decorate these host glycoproteins. To
further test this possibility, b1a n da3 integrins were
immunoprecipitated from 5637 bladder cells that had been
transfected with expression constructs encoding either
Figure 1. Identification of Potential FimH Receptors
Membrane-associated proteins isolated from 5637 bladder epithelial cells
were resolved by SDS-PAGE and transferred to PVDF membrane. Protein
bands bound by purified recombinant FimC6XHisFLAG alone (left) or
FimC6XHisFLAG–FimH complexes in the presence (middle) and absence
(right) of 2.5% D-mannose were detected by chemiluminescence in
overlay assays using anti-FLAG antibody. The two most prominent bands
bound by the FimC6XHisFLAG–FimH complexes were found by mass
spectroscopy analysis to be comprised of a2, b1, a3, a6, and b4 integrins.
Molecular weight standards are indicated on the left.
doi:10.1371/journal.ppat.0030100.g001
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UPEC Invasion via Integrin ReceptorsV5His-tagged human b1 or untagged a3 integrin. Immuno-
precipitates were split up and mock treated or treated with
either of the glycosidases EndoHf or PNGase F. Samples were
then resolved by SDS-PAGE and transferred to PVDF
membranes. EndoHf cleaves high mannose and hybrid
oligosaccharides from N-linked glycoproteins, while PNGase
F cleaves all N-linked sugars. Western blot analysis using anti–
b1 and anti–a3 integrin antibodies showed that the glyco-
sidase treatments caused large decreases in the apparent
molecular weights of both integrins, reﬂective of their
deglycosylated status (Figure 4A and 4B). In Far Western
overlay assays, puriﬁed FimC6XHisFLAG–FimH complexes
interacted poorly or not at all with the deglycosylated forms
of the b1 and a3 integrins, but bound well to the untreated
integrin bands. Neither FimC6XHisFLAG–FimH complexes in
the presence of 2.5% D-mannose nor FimC6XHisFLAG alone
bound to the untreated b1 and a3 integrin bands (Figure 4A
and 4B). The faint bands seen in the Far Western blot shown
in Figure 4B may reﬂect weak interactions between FimH and
deglycosylated or partially glycosylated forms of a3 integrin—
these faint bands were not detected in the presence of D-
mannose or when blots were incubated with only puriﬁed
FimC6XHisFLAG. Cumulatively, these results demonstrate that
FimH can directly bind both b1 and a3 integrin subunits
individually and that these interactions are highly dependent
on the presence of N-linked oligosaccharides.
Phosphorylation Sites within the Cytoplasmic Tail of b1
Integrin Modulate Entry of Type 1–Piliated E. coli
To conﬁrm and further deﬁne the role of b1 integrin as a
facilitator of host cell invasion by type 1–piliated E. coli, we
performed cell association and gentamicin protection–based
invasion assays with a mouse embryonic ﬁbroblast cell line,
GD25, in which the gene encoding b1 integrin has been
inactivated [56,57]. Comparisons were made with a stably
transfected derivative of the GD25 cell line, GD25-b1A, that
encodes the widely expressed wild-type b1 integrin splice
variant, b1A. In these and related assays described below, the
number of intracellular bacteria recovered was divided by the
number of total cell-associated bacteria as a means to
normalize the data, accounting for possible variations in host
cell numbers [51]. Entry of UTI89, as well as the type 1–
piliated K-12 strain AAEC185/pSH2, into the b1 integrin–null
GD25 cells was signiﬁcantly decreased relative to the control
GD25-b1A cells (Figure 5A and 5C). In contrast, the numbers
of cell-associated bacteria did not notably differ between
these two host cell lines (Figure 5B and 5D). These data verify
that b1 integrin is a major, but probably not an exclusive,
mediator of host cell invasion by type 1–piliated E. coli strains.
b1 integrin contains ﬁve potential phosphorylation sites
(Y783, S785, T788, T789, and Y795) within the terminal 16
amino acids of its cytoplasmic tail [58]. Mutation of these
phosphorylation sites can variably affect cellular attachment
to ECM components as well as cell spreading and migration
Figure 2. Anti–b1 and Anti–a3 Integrin Antibodies Inhibit Host Cell Invasion by Type 1–Piliated E. coli
5637 bladder epithelial cell monolayers were treated with 1.5 lg/well of the indicated monoclonal antibodies for 30 min prior to infection with the
UPEC cystitis isolate UTI89 or AAEC185/pSH2, a type 1 pili–expressing recombinant K-12 strain. Shown are (A and C) intracellular bacterial titers,
determined using gentamicin protection assays, and (B and D) total cell-associated bacteria (including both intra- and extracellular bacteria). Data are
expressed as the means 6 standard error of the mean of at least three independent experiments carried out in triplicate. * p , 0.001, versus untreated
control (Ctrl) values, as determined by Student’s t-test.
doi:10.1371/journal.ppat.0030100.g002
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UPEC Invasion via Integrin Receptors[58–60]. To address the roles of these phosphorylation sites
within the cytoplasmic tail of b1 integrin in host cell invasion
by type 1–piliated E. coli, we utilized three derivatives of the
GD25 cell line: GD25-b1ATT788/9A, GD25-b1AY783/795F, and
GD25-b1AS785A cells. GD25-b1ATT788/9A cells have T to A
mutations at threonine residues T788 and T789 within the
cytoplasmic tail of b1A integrin that render the ligand-
binding extracellular domain of this integrin inactive and
unable to mediate cellular adhesion to laminin and ﬁbro-
nectin [58,59]. In GD25-b1AY783/795F cells, tyrosine residues
Y783 and Y795 of b1A integrin have been replaced with
phenylalanines, resulting in decreased cell migration pre-
Figure 3. Localization of b1 and a3 Integrins with Type 1 Pili–Expressing
E. coli
5637 bladder cells were infected for 30 min with (A–D) UTI89 or (E–G)
AAEC185/pSH2 prior to fixation and processing for immunofluorescent
confocal microscopy. Samples were stained using antibodies specific for
the following individual integrin subunits: (A and E) b1, (B and F) a3, or
(C, D and G) heterodimeric a3b1 integrin complexes (green in the
merged color images). F-actin (red) was visualized using Alexa568-
conjugated phalloidin, while bacteria (blue) were detected using anti–E.
coli antibody. For clarity, the merged color image in each row is
Figure 4. Glycosidase Treatment Abrogates In Vitro Binding of FimH to
b1 and a3 Integrins
(A) b1 and (B) a3 integrins were immunoprecipitated from 5637 cells
that had been transiently transfected with plasmids for overexpression
of recombinant human b1o ra3 integrins. The immunoprecipitated
proteins were treated 6 glycosidases (endoglycosidase Hf [EndoHf] or
Peptide: N-glycosidase F [PNGase]) prior to SDS-PAGE and transfer to
PVDF membranes. Blots were probed with either (A) anti–b1 or (B) anti–
a3 integrin antibodies (Westerns), revealing expected shifts in the
electrophoretic mobility of both integrin subunits following glyco-
sidase treatments. For each set of samples, duplicate blots were
overlaid with purified recombinant FimC6XHisFLAG–FimH complexes and
probed with anti-FLAG tag antibody (Far Westerns). As additional
controls, blots containing untreated b1o ra3 integrins were also
incubated with either FimC6XHisFLAG–FimH complexes plus 2.5% D-
mannose or with FimC6XHisFLAG alone. Molecular weight standards are
indicated on the left.
doi:10.1371/journal.ppat.0030100.g004
accompanied by images showing only corresponding single channel
signals from integrin or F-actin staining. Arrowheads denote the location
of an individual bacterium in each set of images. Based on optical
sectioning, the highlighted bacteria in (A–C) and (E–G) were localized at
or very near the host cell surface, while the bacteria in (D) have already
completely penetrated the target host cell.
Scale bar ¼ 10 lm.
doi:10.1371/journal.ppat.0030100.g003
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UPEC Invasion via Integrin Receptorssumptively due to reduced activation of FAK, a key regulator
of focal adhesion and actin dynamics [61]. In GD25-b1AS785A
cells, serine residue S785 within the tail of b1A integrin was
mutated to alanine. While no glaring phenotypic effect due to
this particular amino acid substitution has been reported yet,
other mutations at this site indicate a role for S785
phosphorylation as a modulator of cell attachment, spread-
ing, and migration [60].
Results from invasion assays using GD25-b1ATT788/9A,
GD25-b1AY783/795F, and GD25-b1AS785A cells infected with
either UTI89 or AAEC185/pSH2 are included as part of
Figure 5A and 5C. Similar trends were observed for both
UTI89- and AAEC185/pSH2-infected samples. Relative to the
GD25-b1A cells, bacterial entry into both GD25-b1AY783/795F
and GD25-b1ATT788/9A cells was signiﬁcantly reduced. In
contrast, bacterial invasion of GD25-b1S785A host cells was
notably and reproducibly enhanced. The numbers of total
bacteria that could associate with these different host cell
lines were similar, with the exception of the GD25-b1S785A
cells (Figure 5B and 5D). On average, nearly twice as many
type 1–piliated bacteria associated with the GD25-b1S785A
cells in comparison with the parent GD25 cells.
Flow cytometry analysis conﬁrmed that the GD25 cell line
lacked b1 integrin surface expression and also revealed some
variation in the levels of b1 integrin surface expression
among the different GD25 derivatives (Table 1). Higher levels
of b1 integrin expression on the surface of GD25-b1S785A cells
may contribute to their relative enhanced capacity to bind
and internalize type 1–piliated bacteria. However, b1 integrin
expression levels did not necessarily correlate with the ability
of the bacteria to either associate with or invade the other
GD25 cell line derivatives (Figure 5 and Table 1). For
example, in our experiments, GD25-b1AY783/795F cells con-
sistently expressed higher levels of surface-localized b1
integrin than GD25-b1S785A cells, yet the GD25-b1AY783/795F
cells were bound by fewer bacteria and were considerably less
susceptible to invasion by type 1 pili–expressing E. coli.
Cumulatively, these data indicate that phosphorylation site-
speciﬁc mutations within the b1 integrin cytoplasmic tail can
differentially affect host cell invasion by type 1–piliated E. coli
strains. However, these effects are not entirely attributable to
variances in receptor availability or bacterial adhesion
frequencies and may instead be a consequence of aberrant
integrin-linked signaling events.
Host Cell Invasion by Type 1–Piliated E. coli Requires Src
and FAK
Ligand-induced clustering and activation of integrin
receptors can stimulate a number of signal transduction
pathways that often rely on Src family kinases and FAK
Figure 5. b1 Integrin Cytoplasmic Tail Mutants Differentially Affect FimH-Mediated Bacterial Invasion of Host Cells
b1 integrin–null GD25 cells, as well as GD25 derivatives that constitutively express wild-type or the indicated mutant forms of b1 integrin, were infected
with (A and B) UTI89 or (C and D) AAEC185/pSH2. Levels of intracellular bacteria (A and C) were normalized among the different host cell lines by
dividing the numbers of intracellular, gentamicin-protected bacteria by the number of total cell-associated bacteria (B and D). Data are expressed
relative to results from GD25-b1A control cells and represent the means 6 standard error of the mean of at least five independent experiments
performed in triplicate. * p , 0.001, versus values from control GD25-b1A cells, as determined by Student’s t-test.
doi:10.1371/journal.ppat.0030100.g005
Table 1. b1 Integrin Expression as Determined by Flow
Cytometry
Cell Line HMb1–1 (b1)
GD25 2.52 6 0.06
GD25-b1A 7.46 6 0.12
GD25-b1ATT788/9A 7.54 6 0.37
GD25-b1AY783/795F 16.93 6 0.18
GD25-b1AS785A 11.42 6 0.30
Values are the means 6 standard deviation of the fluorescence peak channel intensities
from a representative experiment repeated in triplicate. GD25 values are considered as
background. Flow cytometry was performed as described in Materials and Methods.
doi:10.1371/journal.ppat.0030100.t001
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UPEC Invasion via Integrin Receptors[62,63]. The engagement of integrin receptors promotes
autophosphorylation of FAK at tyrosine 397, creating a
high-afﬁnity binding site for several Src homology 2 (SH2)
domain-containing proteins, including Src tyrosine kinase.
Binding to FAK stimulates Src kinase activity, which in turn
promotes further phosphorylation and maximal activation of
FAK. The resultant dual-activated Src–FAK signaling com-
plex acts to recruit and/or phosphorylate several adaptor and
signaling factors that can modulate a variety of host cell
functions, including actin dynamics. This link between
integrin receptors and downstream signaling through Src
family kinases and FAK suggested a role for these tyrosine
kinases in FimH-mediated invasion of host cells by UPEC. To
address this possibility, we ﬁrst investigated the involvement
of Src family kinases in UPEC invasion using two structurally
related Src family kinase inhibitors, PP1 and PP2 [64].
Treatment with either PP1 or PP2 greatly inhibited the
ability of UTI89 to invade 5637 bladder epithelial cells
(Figure 6A). In contrast, treatment of host cells with PP3, an
inactive analog of both PP1 and PP2, had almost no effect.
Notably, these compounds did not interfere with bacterial
association with the host cells (Figure 6B) and did not affect
host cell or bacterial viability during the course of the
experiments (unpublished data).
To examine the role of FAK in host cell invasion by type 1–
piliated UPEC, 5637 bladder cells were transfected with small
interfering RNA (siRNA) speciﬁc for FAK or with control
scrambled nonspeciﬁc siRNA. After 72 h, bacterial invasion
and cell association assays were performed using the siRNA-
transfected cells. FAK knockdown signiﬁcantly reduced the
ability of UTI89 to enter host 5637 cells by about 40% (Figure
6C), but did not affect the total numbers of host cell-
associated bacteria (Figure 6D). Knockdown of FAK protein
expression was veriﬁed by Western blot analysis, which
indicated an approximately 65% reduction in FAK levels
relative to levels of control samples that were transfected with
nonspeciﬁc siRNA (Figure 6C, inset). To conﬁrm the results
from these siRNA experiments, we employed a mouse embryo
ﬁbroblast cell line that that does not express FAK (FAK / 
cells) [65]. FAKþ/þ ﬁbroblasts derived from littermates of the
Figure 6. FimH-Mediated Bacterial Invasion of Host Cells Requires Src Family Kinases and FAK
(A and B) 5637 cells were treated with 20 lg/ml of the Src family kinase inhibitors PP1 or PP2 or with an inactive analog, PP3, for 1 h prior to infection
with UTI89. Levels of intracellular bacteria as determined by gentamicin protection assays (A) or total cell-associated bacteria (B) are expressed relative
to results from cells treated with carrier (DMSO) alone.
(C and D) Alternately, 5637 cells were transfected with either scrambled control siRNA or siRNA with specificity against FAK. Cells were infected with
UTI89 at 72 h after siRNA transfection and intracellular (C) and total cell-associated (D) bacterial counts were determined. FAK knockdown was verified
by Western blot analysis using antibody specific for total FAK ([C], inset). Blots were also probed using anti-actin antibody as a protein loading control.
(E and F) Intracellular (E) and total cell-associated (F) bacteria were also quantified in assays using FAK /  and control FAKþ/þ mouse embryo
fibroblasts. Intracellular bacterial levels were normalized in all assays by dividing the numbers of intracellular, gentamicin-protected bacteria by the
number of total cell-associated bacteria. Data are expressed relative to results from the indicated control samples and represent the means 6 standard
error of the mean of three independent experiments performed in triplicate. * p , 0.001, versus values from control samples, as determined by
Student’s t-test.
doi:10.1371/journal.ppat.0030100.g006
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invasion of the FAK /  cells was substantially inhibited
relative to control cells (Figure 6E), while total numbers of
cell-associated bacteria did not signiﬁcantly vary between the
two host cell lines (Figure 6F). Together, the results presented
in Figure 6 demonstrate a requirement for both Src family
kinases and FAK during FimH-mediated host cell invasion by
UPEC.
Discussion
In this study, we show that b1 and a3 integrins mediate
entry of type 1–piliated E. coli into host cells. While other
receptors for FimH have been previously identiﬁed, to our
knowledge b1 and a3 integrins are the ﬁrst demonstrated to
be functionally important for UPEC invasion of uroepithelial
cells. As a heterodimer, a3b1 integrin can bind a number of
ECM components, including laminin, ﬁbronectin, and colla-
gen [66]. Recognition of ECM proteins allows many pathogens
to interact indirectly with host integrin receptors [45]. FimH
itself is able to bind the matrix-associated proteins laminin,
ﬁbronectin, and type IV collagens, which could in turn link
UPEC with integrin receptors [32–34]. However, our results
using Far Western overlay assays indicate that FimH can
directly engage both b1 and a3 integrins, without the need for
ECM components to bridge the interactions.
The carbohydrate-binding pocket at the distal tip of the
adhesion domain of FimH accommodates a-linked mannose,
either in free form or at the non-reducing end of a glycan
[26,67]. Integrins can be differentially glycosylated depending
on the cell line or cell type observed, and the number and
types of glycosylations can affect integrin conformation and
function [68–74]. Within their extracellular domains, the b1
and a3 integrin subunits have 12 and 13 putative N-linked
glycosylation sites, respectively, and in the case of b1 integrin,
ten of the 12 potential N-glycosylation sites appear to be
utilized [75]. The N-linked glycans associated with both b1
and a3 subunits from different normal and cancerous
urothelial cell lines are quite heterogeneous, with complex
type oligosaccharides predominating over high-mannose type
structures [72,76]. In the normal human urothelial cell line
HCV29, the high-mannose glycans associated with both b1
and a3 subunits have terminally exposed mannose residues
[76]. Although integrins with high-mannose type glycans
constitute only a small fraction of the total integrin pool, the
types of high-mannose structures present on this fraction are
representative of those that are potentially able to interact
with FimH. In particular, these high-mannose type glycans
(Man8GlcNAc2 in both a3a n db1 integrin, along with
Man6GlcNAc2 and Man7GlcNAc2 structures in b1 integrin)
are similar to those that decorate an established FimH
receptor, UP1a [77].
We have found that FimH binding to both a3 and b1
integrin subunits is competitively inhibited by the soluble
receptor analog D-mannose, which suggests that the carbo-
hydrate-binding pocket of the adhesin mediates FimH-
integrin interactions. Furthermore, enzymatic deglycosyla-
tion of the integrin subunits abrogates interactions with
FimH in overlay assays. Together, these results indicate that
FimH recognizes one or more N-linked high-mannose
oligosaccharides associated with each of the target integrins.
The ability of FimH to bind the a3 and b1 subunits separately
indicates that these interactions occur independently of the
canonical ligand-binding pocket formed by intact a3b1
receptor heterodimers. Fine mapping of the interactions
between FimH and the a3 and b1 integrin subunits awaits
further studies.
The engagement of extracellular ligands induces integrin
clustering, which in turn can enhance the ligand binding
avidity of integrin receptors as well as activate downstream
signaling events [43,78]. Previous work has already suggested
that FimH-mediated invasion of bladder epithelial cells
involves the induced clustering of host receptors [14,18]. By
transmission electron microscopy, electron-dense material,
which likely represents receptors and other host proteins,
accumulates in the host membrane beneath adherent
bacteria and FimH-coated beads as they are internalized.
Results from immunoﬂuorescence microscopy presented
here indicate that a3b1 integrin heterodimers in bladder
epithelial cells co-localize around adherent and invading type
1–piliated E. coli (see Figure 3). We have also noted the
accumulation of F-actin around adherent and internalized
bacteria in association with the integrin receptors.
F-actin dynamics are modulated downstream of integrin
clustering by the recruitment and/or activation of a number
of adaptor proteins, Rho family GTPases and kinases [79].
Several of these factors have been implicated as regulators of
host cell invasion by type 1–piliated bacteria. These include
the actin adaptor and bundling components vinculin and a-
actinin, the Rho GTPases Cdc42 and Rac1, PI 3-kinase, and
FAK [18,29]. Infection of bladder epithelial cells with type 1–
piliated E. coli stimulates phosphorylation of FAK at Y397 and
promotes transient complex formation between FAK and PI
3-kinase [18]. Interactions with FAK activate PI 3-kinase and
thereby elicit the generation of 3-phosphoinositide second
messengers that can alter actin cytoskeletal dynamics via a
number of direct and indirect mechanisms [80–82]. Pharma-
cological inhibition of PI 3-kinase activity using either
wortmannin or LY294002 has been shown to greatly reduce
invasion of 5637 bladder cells by type 1–piliated bacteria [18].
Here, using siRNA and a FAK-null cell line, we have
demonstrated that FAK itself is also required for FimH-
mediated entry of UPEC into host cells. Maximal activation of
FAK is stimulated by interactions with Src family kinases
[62,63]. We have found that inhibition of Src family kinases
using either the PP1 or PP2 inhibitor signiﬁcantly interferes
with FimH-mediated invasion of host bladder cells by UPEC.
In contrast, an inactive analog of these inhibitors had only a
modest effect. It should be noted that, for unknown reasons, a
previous study using only the PP1 inhibitor failed to indicate
a role for Src family kinases in FimH-mediated bacterial
invasion [18].
FAK positively and negatively regulates multiple signaling
molecules, including the Rho family GTPases Rac1 and Cdc42
[62]. Both of these GTPases appear to modulate FimH-
dependent bacterial invasion of host bladder cells in possible
conjunction with a-actinin and vinculin [29]. The adaptor
protein a-actinin is itself a substrate for FAK, and the
infection of bladder cells with type 1–piliated E. coli
stimulates complex formation between a-actinin and vinculin
[18]. These complexes can crosslink actin stress ﬁbers and
tether them to integrin receptor complexes via interactions
with integrin-binding proteins such as paxillin and talin [63].
The recruitment of FAK and these various other host factors
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and spatially regulated by a number of different mechanisms,
including phosphorylation. Mutational analyses of threonine,
tyrosine, and serine residues within the cytoplasmic tail of b1
integrin indicate variable roles for these putative phosphor-
ylation sites during host cell invasion by type 1–piliated E. coli.
Threonine residues T788 and T789 modulate the active
conformation of the extracellular domain of b1 integrin via a
so-called inside-out signaling process [58]. Inside-out signal-
ing occurs when cytoplasmic signals confer a large conforma-
tional change to the integrin extracellular domain,
converting the integrin from an inactive state to an active,
high-afﬁnity ligand-binding receptor [78]. The replacement
of threonine residues T788 and T789 in the tail of b1 integrin
with alanines alters the extracellular domain of the receptor
so that it is inactive and can no longer bind ﬁbronectin [58]. It
is speculated that in wild-type cells, the phosphorylation of
T788 and/or T789 is one means by which integrin inside-out
signaling is regulated [58,83]. We have found that expression
of the TT788/789AA mutant b1 integrin renders host cells
refractory to invasion by type 1–piliated E. coli. Potentially,
FimH interactions with b1 integrin in its activated state
better promotes bacterial entry.
Tyrosine residues Y783 and Y795 within the cytoplasmic
tail of b1 integrin may inﬂuence FimH-mediated bacterial
invasion of host cells by altering both inside-out and outside-
in signaling processes. Y783 and Y795 are part of two highly
conserved NPxY motifs within the tail of b integrin subunits
that act as speciﬁc binding sites for phosphotyrosine-binding
domain-containing proteins, including b1 integrin cytoplas-
mic domain associated protein-1 and the focal adhesion
components tensin and talin [84,85]. Binding of talin to NPxY
motifs is thought to be required for inside-out activation of b
integrins [86]. Mutation of the two tyrosines within the NPxY
motifs of b1 integrin to alanines (Y783/795A) results in the
complete loss of b1 integrin function [87,88]. In contrast, the
replacement of these tyrosine residues with phenylalanines
(Y783/795F), which partially mimic the hydrophobic aromatic
ring structure of tyrosine and cannot be phosphorylated,
preserves b1 integrin function during development in vivo
[89,87]. These results indicate that the phosphorylation of
Y783 and Y795 is not required for proper b1 integrin
function under normal physiological conditions. However,
earlier studies indicated that activation of FAK and cell
migration is diminished in cultured cells that express b1AY783/
795F integrin, which suggests that phosphorylation of Y783
and Y795 can alter integrin function in some situations
[59,61]. In our assays, FimH-dependent bacterial invasion of
GD25-b1AY783/795F host cells was signiﬁcantly inhibited
relative to control cells expressing wild-type b1 integrin.
Similar results were previously reported for Staphylococcus
aureus, a pathogen that invades host cells via a5b1 integrin
receptors [90]. These ﬁndings contrast with those reported
for Yersinia invasin-mediated entry into host cells via b1
integrin receptors, where the Y783/795F mutations were
inconsequential [91]. The basis for these contrary outcomes is
not clear, but they may reﬂect variations in the ways in which
different bacterial pathogens engage and signal through
integrin receptors.
In contrast to the T788/789A and Y783/795F mutations, the
S785A mutation in the tail of b1 integrin signiﬁcantly
enhanced FimH-dependent bacterial invasion frequencies,
which corresponded to a degree with increases in the number
of total host cell–associated bacteria. Surface expression of b1
integrin in the GD25-b1AS785A cell line was somewhat
elevated relative to that of GD25-b1A control cells, and this
could contribute to the observed effects. In addition, the
S785A mutation may boost bacterial invasion frequencies by
altering integrin-mediated signaling events. For example, it
has been shown that mutations at S785 that mimic either de-
phosphorylated or phosphorylated forms of serine differ-
entially affect cell attachment, spreading, and migration [60].
Based on these observations, we suggest that S785 is an
important regulator of b1 integrin signaling during FimH-
mediated bacterial invasion, but the speciﬁc mechanism by
which this residue affects the invasion process is not yet clear.
A critical feature of any host receptor is its location and
availability on cells and within tissues that are targeted by
incoming pathogens. As shown here, and by others [72,76],
both b1 and a3 integrins are expressed by undifferentiated
bladder epithelial cells. Furthermore, Southgate and col-
leagues have found that both b1a n da3 integrins are
expressed in all strata of urothelia from the bladder, ureter,
and renal pelvis [92]. Thus, b1 and a3 integrin subunits are
well situated to act as receptors for UPEC entry into both the
terminally differentiated superﬁcial umbrella cells and the
underlying immature cells of the urothelium. However, it is
likely that other host proteins can also promote UPEC
invasion of host urothelial cells. For example, in addition to
b1 and a3 integrins, three other integrin subunits (a2, a6, and
b4) are also prevalent within the normal human urothelium
[92] and were picked up as potential FimH receptors in our
initial screen. It is conceivable that one or more of these
other integrin subunits may also facilitate FimH-mediated
bacterial entry, but this was not demonstrable using available
antibodies.
Due to its prevalence within the urinary tract, UP1a has
received substantial attention as the canonical FimH recep-
tor. Interestingly, UP1a is a member of a superfamily of
membrane proteins known as tetraspanins that often com-
plex with b1 integrin receptors [93]. It is thought that
tetraspanins modulate integrin-dependent signaling as well as
integrin trafﬁcking and compartmentalization within lipid
rafts on the cell surface. As already noted, FimH-mediated
bacterial invasion of host bladder cells is apparently depend-
ent upon lipid rafts [30]. Another tetraspanin protein, CD151,
forms a particularly strong association with a3b1 receptors
and potentiates integrin ligand-binding activity [94,95].
CD151/a3b1 integrin complexes interact with the comple-
ment receptor CD46 (membrane cofactor protein), a host
protein that has recently been shown to enhance the efﬁcacy
of type 1 pilus–mediated bacterial invasion of human urinary
tract epithelial cells [16,96]. These observations suggest the
existence of an interconnected web of host receptors, co-
receptors, and signaling molecules that can be recruited by
type 1–piliated UPEC in order to facilitate its entry into
target urothelial cells.
In addition to their roles as mediators of cell attachment,
migration, and spreading, integrins are also important
modulators of many other processes, including differentia-
tion and apoptosis [43]. The capacity of FimH to bind a3b1
integrin, and perhaps other integrin subunits within the
urothelium, raises the possibility that FimH effects extend
beyond host cell adherence and invasion during the course of
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intercellular junctions could conceivably expedite bladder
cell exfoliation and disruption of the urothelium barrier, a
phenomenon that may promote UPEC dissemination within
the urinary tract [1,8]. Furthermore, the recognition of a3b1
receptors by FimH may also modulate bacteria–host inter-
actions outside the urinary tract. In addition to UPEC, most
other extraintestinal pathogenic E. coli isolates and many
other members of the Enterobacteriaceae family (including
both commensal and pathogenic organisms) encode type 1
pili. These microbes are therefore potentially capable of
binding and manipulating a3b1 integrin receptors that are
expressed by a number of different host cell types and tissues
within varied niches throughout the host.
Materials and Methods
Cell lines, bacterial strains, and plasmids. The human bladder
epithelial cell line 5637 (ATCC HTB-9; American Type Culture
Collection, http://www.atcc.org/) was maintained in RPMI 1640
medium (Invitrogen, http://www.invitrogen.com/) supplemented with
10% heat inactivated fetal bovine serum (FBS) (HyClone, http://www.
hyclone.com/) at 37 8Ci n5 %C O 2. The b1 integrin–null cell line
GD25 and its stably transfected b1 integrin–expressing derivatives
GD25-b1A, GD25-b1AS785A, GD25-b1ATT788/9A, and GD25-b1AY783/
795F (kindly provided by S. Johansson, The Biomedical Center,
Uppsala, Sweden) were cultured in DMEM plus 10% FBS [56,57].
Puromycin (Sigma-Aldrich, http://www.sigmaaldrich.com/), at a con-
centration of 10 lg/ml, was used to maintain the stably transfected
GD25 cell lines. The FAK-null mouse embryonic ﬁbroblast cell line
(FAK / ; ATCC CRL-2644) and the control cell line (FAKþ/þ; ATCC
CRL-2645) were maintained in DMEM plus 10% FBS. UTI89, a well-
characterized human cystitis isolate, and the recombinant K-12 E. coli
strains AAEC185/pSH2 (type 1 pili
þ) and AAEC185/pUT2002 (type 1
pili
þ/DﬁmH ), have been described [8,9,52]. Targeted deletion of ﬁmH
in UTI89 was accomplished by lambda Red–mediated linear trans-
formation and veriﬁed by PCR as well as by yeast and red blood cell
agglutination assays [97]. These strains were grown at 37 8Ci n2 0m l
static Luria Bertani (LB) broth cultures for 48 h to stimulate
expression of type 1 pili. pcDNA4A(b1_V5His6), which encodes
the human b1A isoform with N-terminal V5 and 6XHis epitope tags,
was generously provided by S. Kuwada (University of Utah, Salt Lake
city, Utah, United States) [98]. pCMVzeo-ha3A, which encodes human
a3 integrin, was provided by M. E. Hemler (Harvard Medical School,
Boston, Massachusetts, United States) [99].
For coordinate expression and puriﬁcation of FimC and FimH, we
constructed a dual cistronic plasmid pJLJ200 encoding FimC with a
COOH-terminal 6XHisFLAG-tag fusion and wild-type FimH under
control of independent T7 promoters. ﬁmC and ﬁmH were ampliﬁed
from plasmid pSH2 [100] using primers Cfor1 (59-TGATACCATGGT-
GAGTAATAAAAACGTCAATG-39), Crev2_HisFLAGN (59-ACGT-
TAAGCTTATCCCTTATCGTCGTCATCCTTGTAGTCGTGGTGAT-
GATGGTGATGTTCCATTACGCCCGTCATTT-39), Hfor1 (59-
TTCAGCATATGAAACGAGTTATTACCCTGT-39), and Hrev1 (59-
ACTTACTCGAGTTATTGATAAACAAAAGTCACGA-39). The dou-
bly underlined sequences indicate, respectively, NcoI, HindIII, NdeI,
and XhoI sites that were introduced for cloning purposes. Singly
underlined sequences indicate homology regions to the targeted ﬁmC
and ﬁmH genes. Crev2_HisFLAGN was used to append sequences
encoding adjacent 6XHis and FLAG tags at the COOH-terminus of
FimC. Ampliﬁed ﬁmC6XHisFLAG and ﬁmH PCR products were digested
using appropriate restriction enzymes and ligated, respectively, into
multiple cloning sites 1 and 2 of pETDuet-1 (Novagen, http://www.
emdbiosciences.com/html/NVG/home.html) to create pJLJ200. A
construct encoding FimC6XHisFLAG by itself was designated pJLJ300.
For expression of recombinant proteins, the E. coli strain BL21(DE3)
(Novagen) encoding isopropyl-1-thio-b-D-galactopyranoside (IPTG)-
inducible T7 polymerase was transformed with either pJLJ200 or
pJLJ300.
FimC and FimCH puriﬁcation. BL21(DE3)/pJLJ200 was inoculated
1:100 from an overnight culture into 2 L of LB broth plus 100 ug of
ampicillin/ml (Sigma-Aldrich) and grown shaking at 37 8C to a density
of OD600 ;0.6. At this point, expression of FimC6XHisFLAG and FimH
was induced by addition of 1 mM IPTG for 3 h. Bacteria were then
pelleted, resuspended in cold 20 mM Tris (pH 8.0)/20% sucrose, and
lysed on ice by addition of 5 lM EDTA and 75 lg of lysozyme/ml for 30
min. Next, 10 mM MgCl2 was added and unbroken bacteria and large
debris were pelleted at 10,000g for 20 min at 4 8C. The supernatant,
containing periplasmic proteins, was dialyzed against 20 mM Tris (pH
8.0) and loaded on Ni-NTA agarose columns (Qiagen, http://www.
qiagen.com/). The column was washed with 20X column volumes of
washbuffer (20 mMTris [pH8.0],150 mMNaCl, and 20mM imidazole)
prior to elution of FimC6XHisFLAG–FimH complexes using 250 mM
imidazole. Complexes were further puriﬁed using an anti-FLAG M2
agarose column (Sigma-Aldrich). Bound FimC6XHisFLAG and associ-
ated FimH were washed with 15X column volumes of Tris-buffered
saline (TBS, pH 7.4) prior to elution using 5 mg of FLAG peptide/ml
(Sigma-Aldrich). Following the same protocol, FimC6XHisFLAG in the
absence of FimH was puriﬁed from strain BL21(DE3)/pJLJ300. The
purity of the recovered recombinant proteins was determined by
Western blot analysis and GelCode Blue–stained gels (Pierce, http://
www.piercenet.com/).
Overlay assays and identiﬁcation of candidate receptors. The
membrane fraction from two conﬂuent T75 ﬂasks of 5637 bladder
epithelial cell monolayers was isolated using an established protocol
[101]. Brieﬂy, cells were recovered by scraping into cold phosphate
buffered saline (PBS), pelleted at 600g for 5 min, resuspended in 1 ml
of HN buffer (5 mM HEPES [pH 7.5], 0.25 M sucrose) plus protease
inhibitors (including 200 lM PMSF and a 1X protease inhibitor
cocktail; Roche, http://www.roche.com/) and Dounce homogenized.
Cell debris was removed by centrifugation at 600g for 10 min, and
membranes in the resultant supernatant were pelleted by spinning at
10,000g for 30 min at 4 8C. The membrane pellet was lysed in 110 llo f
2X sample buffer (78 mM Tris [pH 6.8], 1% 2-mercaptoethanol,
0.001% bromophenol blue, 10% glycerol, 3% SDS) and heated for 5
min at 100 8C. Triplicate 20-ll aliquots, along with molecular weight
standards in adjacent lanes, were resolved by SDS-PAGE using 12%
polyacrylamide gels. Proteins from one set of lanes were stained using
GelCode Blue while the other two sets were transferred to PVDF
membrane and incubated for 20 min at room temperature in
blocking buffer (TBSþ0.1% Tween-20 [TBS-T, pH 7.4], 1% BSA, and
1% powdered milk). Blocked membranes were then incubated for 90
min with 150 ug of puriﬁed recombinant FimC6XHisFLAG alone or
puriﬁed FimC6XHisFLAG–FimH complexes in 3 ml of blocking buffer
þ/  2.5% D-mannose. Following 3 3 3-min washes with TBS-T, the
membranes were incubated for 45 min with an anti-FLAG mono-
clonal antibody (diluted 1:1000; Sigma-Aldrich). After a ﬁnal 30-min
incubation with secondary anti-mouse IgG-HRP conjugate (1:10,000;
Amersham Biosciences, http://www.gelifesciences.com/), blots were
washed, developed using SuperSignal West Pico Chemiluminescent
Substrate (Pierce), and exposed to CL-XPosure Film (Pierce). Host
protein bands that bound puriﬁed FimC6XHisFLAG–FimH complexes,
as determined by this overlay assay, were excised from the
corresponding GelCode Blue–stained gel, subjected to in-gel trypsin
digestion, and identiﬁed using liquid chromatography/mass spec-
trometry at the University of Utah core facility.
Integrin immunoprecipitation and glycosidase treatments. 5637
cells at 80% conﬂuency were transfected with pcDNA4A(b1_V5His6)
or pCMVzeo-ha3A using the LT-1 transfection reagent (Mirus, http://
www.mirusbio.com/). Then, 24 h post-transfection, 5637 monolayers
were lysed in TNN buffer (50 mM Tris [pH 7.4], 150 mM NaCl, 1%
NP-40, and 1X protease inhibitors) for 30 min on ice. Post-nuclear
supernatants were pre-cleared with protein G-coupled agarose beads
(Sigma-Aldrich) for 30 min at 4 8C prior to incubation with
polyclonal anti-V5 tag (2 lg/ml; Bethyl Laboratories, http://www.
bethyl.com/) or rabbit anti–a3 integrin antibody (5 lg/ml; Chemicon,
http://www.chemicon.com/) for an additional 2 h at 4 8C. Immune
complexes were precipitated using protein G-coupled beads and
washed 43 with TNN lysis buffer. The beads were then divided into
three samples and left untreated or treated with either 100 U of
endoglycosidase Hf (EndoHf, 100,000 U/ml; New England Biolabs,
http;//www.neb.com/) or 5 U of Peptide: N-glycosidase F (PNGase F,
5,000 U/ml; New England Biolabs) for 60 min at 37 8C. Each sample
was further divided in three and resolved by SDS-PAGE before
transfer to PVDF membranes. The blots were overlaid with
recombinant FimC6XHisFLAG–FimH complexes, FimC6XHisFLAG–FimH
complexes plus 2.5% D-mannose, or FimC6XHisFLAG alone and probed
using anti-FLAG tag antibody as described above. The same blots
were subsequently incubated with either polyclonal anti–b1 integrin
antibody or rabbit anti–a3 integrin (both at 1:1000, Chemicon).
Following incubations with HRP-tagged secondary antibodies (Amer-
sham Biosciences), blots were washed and developed using Super-
Signal West Pico Chemiluminescent Substrate (Pierce). Alternately,
blots were incubated with IRDye-labeled secondary antibodies and
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Biosciences, http://www.licor.com/).
Invasion and cell association assays. Bacterial invasion and cell
association assays were performed essentially as previously described
[18,51]. Within 24 h of seeding into 24-well plates, triplicate wells of
conﬂuent monolayers of host cells were infected with either UTI89 or
AAEC185/pSH2 at a multiplicity of infection (MOI) of 1–15 bacteria
per host cell. Plates were spun at 600g for 5 min to expedite and
synchronize bacterial contact with the host cell monolayers prior to a
2-h incubation at 37 8C. For cell association assays, host cells were
then washed 43 with PBS
2þ (PBS supplemented with Mg
2þ/Ca
2þ) and
lysed in 1 ml of PBS
2þ containing 0.4% Triton X-100. For invasion
assays, extracellular bacteria were killed following the initial 2-h
incubation period by an additional 2-h incubation in medium
containing the host membrane-impermeable bacteriocidal agent
gentamicin (100 lg/ml; Sigma-Aldrich). Cells were then washed 43
with PBS
2þ and lysed. Bacterial titers in the lysates were determined
by serial dilutions and plating on LB agar plates. Except for the
antibody blocking experiments, all results from invasion assays were
normalized by dividing the number of intracellular bacteria by the
total number of cell-associated bacteria [51]. Levels of intracellular
and cell-associated bacteria were expressed as percentages relative to
control samples, and all assays were repeated three or more times in
triplicate. The signiﬁcance of the observed differences was analyzed
using Student’s t-test (p , 0.05 was considered to be signiﬁcant).
For the antibody blocking experiments, 5637 bladder cell mono-
layers in 24-well plates were pre-incubated with puriﬁed monoclonal
antibodies for 30 min prior to the addition of bacteria. The ﬁnal
concentration of each antibody was 1.5 lg/well. Antibodies against
human b1 (6S6), b4 (ASC-3), a2 (P1E6), and a3 (P1B5) integrins were
purchased from Chemicon, while anti-human a6 integrin (GoH3) and
the b1-activating antibody (P4G11) were obtained from R&D Systems
(http://www.rndsystems.com/). The GoH3 antibody was also purchased
from Abcam (http://www.abcam.com/). To test the role of Src family
kinases on bacterial invasion, 5637 bladder cells were pre-incubated
with PP1 (20 lM; Biomol, http://www.biomol.com/) or PP2 (20 lM;
Calbiochem, http://www.emdbiosciences.com/html/CBC/home.html)
for 1 h prior to infection. Control cells were treated with only the
carrier (DMSO) or with PP3 (20 lM, Calbiochem). None of the
inhibitors or DMSO alone had any effect on host cell or bacterial
viability during the course of the experiments.
To knockdown FAK expression prior to invasion and host cell-
association assays, 5637 cells were transfected with a FAK-speciﬁc
siRNA SmartPool using Dharmafect 1 reagent (Dharmacon, http://
www.dharmacon.com/). Control cells were transfected with scrambled
siRNA. Invasion and cell association assays were performed 72 h after
transfection. In parallel assays, FAK expression was assessed by
Western blot analysis of transfected 5637 cell lysates prepared in
TNN buffer plus protease inhibitors. Protein concentrations from
post-nuclear supernatants were determined using the BCA reagent
system (Pierce). Protein (20 lg) from each sample was resolved by
SDS-PAGE and transferred to Immobilon-FL PVDF membranes
(Millipore, http://www.millipore.com/). Following incubations with
mouse anti-FAK (1:1000, BD Transduction Laboratories, http://www.
bdbiosciences.com/) or mouse anti-actin antibodies (1:400, Abcam),
blots were probed using IRDye-labeled secondary antibodies and
visualized using an Odyssey Infrared Imaging System (LI-COR
Biosciences).
Flow cytometry analysis. The surface expression of b1 integrin by
the GD25 cell line and its derivatives was quantiﬁed by ﬂow
cytometry. Cells (1 3 10
6) were incubated in PBS/2% FBS with a
ﬂuorescein isothiocyanate (FITC)-conjugated b1 integrin–speciﬁc
antibody (HMb1–1; Serotec, http://www.ab-direct.com/) or a FITC-
labeled isotype control for 20 min on ice. After several washes,
samples were assayed by FACScan analysis (Becton Dickinson, http://
www.bd.com/). The mean ﬂuorescence peak channel intensities reﬂect
numbers of surface-localized b1 integrin receptors from HMb1–1–
stained samples. Signals from HMb1–1–stained GD25 cells were
comparable to those seen with samples treated with the isotype
control antibody and is considered background. Three independent
experiments were performed with similar trends in mean ﬂuores-
cence intensities observed each time. However, the actual values
differed depending on variations during the staining and acquisition
setup for each experiment. Therefore, data is presented as the means
þ/  standard deviation from a single representative experiment
repeated in triplicate.
Immunoﬂuorescence microscopy. Thirty minutes post-infection
with wild-type UTI89, DﬁmH UTI89, AAEC185/pSH2, or AAEC185/
pUT2002 (MOI ¼ 1–15), 5637 cells grown on 12-mm-diameter glass
coverslips were washed with cold PBS
2þ and ﬁxed in acetone for 3
min at  20 8C. Samples were then rinsed 3 3 5 min with PBS,
incubated for 30 min in blocking buffer (3% BSA/1% milk/PBS), and
stained using rat anti-human b1 integrin (AIIB2, 1:100; Developmen-
tal Studies Hybridoma Bank at the University of Iowa, http://dshb.
biology.uiowa.edu/), P1B5 (1:500; Chemicon), or mouse anti-a3b1
(1:250; Chemicon) and rabbit anti–E. coli (1:500; BioDesign, http://
meridianlifescience.com/) primary antibodies along with appropriate
Alexa Fluor-conjugated secondary antibodies (1:500; Molecular
Probes/Invitrogen, http://probes.invitrogen.com/). Alexa568-conju-
gated phalloidin (1:40; Molecular Probes) was used to label F-actin.
Following ﬁnal washes in PBS, samples were mounted onto slides
using FluorSave reagent (Calbiochem/EMD Biosciences) and viewed
using an Olympus IX70 FV300 confocal microscope equipped with a
603 oil immersion objective (Olympus PlanApo NA 1.42 Oil
immersion TIRFM), and argon and helium-neon (HeNe) lasers
providing excitation energy at 488, 543, and 633 nm. Images were
captured at the University of Utah School of Medicine Cell Imaging
Facility using Olympus Fluoview software and subsequently analyzed
using Volocity software (Improvision, http://www.improvision.com/).
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